Skip to main content
M. Kyle Jensen
( out of 12 reviews )

M. Kyle Jensen, MD, MS

Languages spoken: English, Spanish

Clinical Locations

Eccles Primary Children's Outpatient Services Building

801-213-3599

Primary Children's Hospital Outpatient Services at Riverton

801-213-3599
  • Dr. Jensen received his medical degree from the University of Utah School of Medicine, completed a pediatric residency at Primary Children’s Hospital, followed by a Pediatric Gastroenterology, Hepatology and Nutrition Fellowship at the Children’s Hospital of Wisconsin in Milwaukee, Wisconsin. He then completed an Advanced Pediatric Hepatology and Transplant Hepatology Fellowship at Cincinnati Children’s Hospital Medical Center in Cincinnati, Ohio. Dr. Jensen is board-certified in Pediatrics, Pediatric Gastroenterology, and Pediatric Transplant Hepatology.

    He is currently a Professor of Pediatrics at the University of Utah in the Division of Pediatric Gastroenterology at Primary Children´s Hospital. His primary clinical interests are in pediatric liver diseases including caring for children who need liver transplantation.

    Dr. Jensen’s research interests include pediatric liver diseases as well as outcomes and quality research in transplantation and pediatric gastroenterology, with an emphasis in epidemiology.

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Gastroenterology)
    Pediatric Transplant Hepatolgoy - Subspecialty

    Patient Rating

    5.0 /5
    ( out of 12 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    August 23, 2023
    PRIMARY CHILDREN'S MEDICAL CENTER

    He Explain things clear so I can understood everything he was saying to me and made me feel comfortable and very positive about the outcome.

    January 17, 2023
    EXTERNAL SITE

    Dr. Jensen and his staff are wonderful!

    January 17, 2023
    EXTERNAL SITE

    Dr. Jensen and his staff are wonderful!

  • Dr. Jensen received his medical degree from the University of Utah School of Medicine, completed a pediatric residency at Primary Children’s Hospital, followed by a Pediatric Gastroenterology, Hepatology and Nutrition Fellowship at the Children’s Hospital of Wisconsin in Milwaukee, Wisconsin. He then completed an Advanced Pediatric Hepatology and Transplant Hepatology Fellowship at Cincinnati Children’s Hospital Medical Center in Cincinnati, Ohio. Dr. Jensen is board-certified in Pediatrics, Pediatric Gastroenterology, and Pediatric Transplant Hepatology.

    He is currently a Professor of Pediatrics at the University of Utah in the Division of Pediatric Gastroenterology at Primary Children´s Hospital. His primary clinical interests are in pediatric liver diseases including caring for children who need liver transplantation.

    Dr. Jensen’s research interests include pediatric liver diseases as well as outcomes and quality research in transplantation and pediatric gastroenterology, with an emphasis in epidemiology.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Academic Divisions Gastroenterology
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Gastroenterology)
    Pediatric Transplant Hepatolgoy - Subspecialty

    Education history

    Fellowship Advanced Hepatology - Cincinnati Children’s Hospital & Medical Center Fellow
    Epidemiology/Clinical and Translational Science - Medical College of Wisconsin M.S.
    Fellowship Pediatric Gastroenterology - Medical College of Wisconsin/Children’s Hospital of Wisconsin Fellow
    Pediatrics - University of Utah, Primary Children’s Medical Center Resident
    Professional Medical Medicine - University of Utah School of Medicine M.D.
    University of Wyoming B.S.

    Selected Publications

    Journal Article

    1. Ricciuto A, Liu K, El-Matary W, Amin M, Amir AZ, Aumar M, Auth M, Di Guglielmo MD, Druve Tavares Fagundes E, Rodrigues Ferreira A, Furuya KN, Gupta N, Guthery S, Horslen SP, Jensen K, Kamath BM, Kerkar N, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Mack C, Martinez M, Montano-Loza A, Ovchinsky N, Papadopoulou A, Perito ER, Sathya P, Schwarz KB, Shah U, Shteyer E, Soufi N, Stevens JP, Taylor A, Tessier ME, Valentino P, Woynarowski M, Deneau M, Pediatric PSC Consortium (2024). Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium. Aliment Pharmacol Ther. (Read full article)
    2. Hansen BE, Vandriel SM, Vig P, Garner W, Mogul DB, Loomes KM, Piccoli DA, Rand EB, Jankowska I, Czubkowski P, Gliwicz-Miedziska D, Gonzales EM, Jacquemin E, Bouligand J, DAntiga L, Nicastro E, Arnell H, Fischler B, Sokal, Demaret T, Siew S, Stormon M, Karpen SJ, Romero R, Ebel NH, Feinstein JA, Roberts AJ, Evans HM, Sundaram SS, Chaidez A, Hardikar W, Shankar S, Fischer RT, Lacaille F, Debray D, Lin HC, Jensen MK, Jaramillo C, Karthikeyan P, Indolfi G, Verkade HJ, Larson-Nath C, Quiros-Tejeira RE, Valentino PL, Rogalidou M, Dezsfi A, Squires JE, Schwarz K, Calvo PL, Bernabeu JQ, Zizzo AN, Nebbia G, Bulut P, Santos-Silva E, Fawaz R, Nastasio S, Karnsakul W, Tamara ML, Busoms CM, Kelly DA, Sandahl TD, Jimenez-Rivera C, Banales JM, Mujawar Q, Li LT, She H, Wang JS, Kim KM, Oh SH, Sanchez MC, Cavalieri ML, Lee WS, Hajinicolaou C, Lertudomphonwanit C, Waisbourd-Zinman O, Arikan C, Alam S, Carvalho E, Melere M, Eshun J, nal Z, Desai DM, Wiecek S, Pinto RB, Wolters VM, Garcia J, Beretta M, Kerkar N, Brecelj J, Rock N, Lurz E, Blondet N, Shah U, Thompson RJ, Kamath BM, Global ALagille Alliance GALA Study Group (2023). Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA. Hepatology. (Read full article)
    3. Lopez-Verdugo F, Sanchez-Garcia J, Baraki S, Kastenberg ZJ, Sanchez-Garavito JE, Zendejas I, Alonso D, Jensen MK, Fujita S, Meyers RL, Book L, Rodriguez-Davalos MI (2023). Utilization of Segmental Grafts is Associated With Higher Transplant Rates in Pediatric Patients. J Surg Res, 290, 28-35. (Read full article)
    4. Vandriel SM, Li LT, She H, Wang JS, Gilbert MA, Jankowska I, Czubkowski P, Gliwicz-Miedziska D, Gonzales EM, Jacquemin E, Bouligand J, Spinner NB, Loomes KM, Piccoli DA, DAntiga L, Nicastro E, Sokal, Demaret T, Ebel NH, Feinstein JA, Fawaz R, Nastasio S, Lacaille F, Debray D, Arnell H, Fischler B, Siew S, Stormon M, Karpen SJ, Romero R, Kim KM, Baek WY, Hardikar W, Shankar S, Roberts AJ, Evans HM, Jensen MK, Kavan M, Sundaram SS, Chaidez A, Karthikeyan P, Sanchez MC, Cavalieri ML, Verkade HJ, Lee WS, Squires JE, Hajinicolaou C, Lertudomphonwanit C, Fischer RT, Larson-Nath C, Mozer-Glassberg Y, Arikan C, Lin HC, Bernabeu JQ, Alam S, Kelly DA, Carvalho E, Ferreira CT, Indolfi G, Quiros-Tejeira RE, Bulut P, Calvo PL, nal Z, Valentino PL, Desai DM, Eshun J, Rogalidou M, Dezsfi A, Wiecek S, Nebbia G, Pinto RB, Wolters VM, Tamara ML, Zizzo AN, Garcia J, Schwarz K, Beretta M, Sandahl TD, Jimenez-Rivera C, Kerkar N, Brecelj J, Mujawar Q, Rock N, Busoms CM, Karnsakul W, Lurz E, Santos-Silva E, Blondet N, Bujanda L, Shah U, Thompson RJ, Hansen BE, Kamath BM, Global ALagille Alliance GALA Study Group (2022). Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study. Hepatology, 77(2), 512-529. (Read full article)
    5. Leung DH, Devaraj S, Goodrich NP, Chen X, Rajapakshe D, Ye W, Andreev V, Minard CG, Guffey D, Molleston JP, Bass LM, Karpen SJ, Kamath BM, Wang KS, Sundaram SS, Rosenthal P, McKiernan P, Loomes KM, Jensen MK, Horslen SP, Bezerra JA, Magee JC, Merion RM, Sokol RJ, Shneider BL, Alonso E, Bass L, Kelly S, Riordan M, Melin-Aldana H, Bezerra J, Bove K, Heubi J, Miethke A, Tiao G, Denlinger J, Chapman E, Sokol R, Feldman A, Mack C, Narkewicz M, Suchy F, Sundaram SS, Van Hove J, Garcia B, Kauma M, Kocher K, Steinbeiss M, Lovell M, Loomes KM, Piccoli D, Rand E, Russo P, Spinner N, Erlichman J, Stalford S, Pakstis D, King S, Squires R, Sindhi R, Venkat V, Bukauskas K, McKiernan P, Haberstroh L, Squires J, Rosenthal P, Bull L, Curry J, Langlois C, Kim G, Teckman J, Kociela V, Nagy R, Patel S, Cerkoski J, Molleston JP, Bozic M, Subbarao G, Klipsch A, Sawyers C, Cummings O, Horslen SP, Murray K, Hsu E, Cooper K, Young M, Finn L, Kamath BM, Ng V, Quammie C, Putra J, Sharma D, Parmar A, Guthery S, Jensen K, Rutherford A, Lowichik A, Book L, Meyers R, Hall T, Wang KS, Michail S, Thomas D, Goodhue C, Kohli R, Wang L, Soufi N, Thomas D, Karpen S, Gupta N, Romero R, Vos MB, Tory R, Berauer JP, Abramowsky C, McFall J, Shneider BL, Harpavat S, Hertel P, Leung D, Tessier M, Schady D, Cavallo L, Olvera D, Banks C, Tsai C, Thompson R, Doo E, Hoofnagle J, Sherker A, Torrance R, Hall S, Magee J, Merion R, Spino C, Ye W, Childhood Liver Disease Research Network (2022). Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease. Hepatology, 77(2), 530-545. (Read full article)
    6. Conover KR, Absah I, Ballal S, Brumbaugh D, Cho S, Cardenas MC, Knackstedt ED, Goyal A, Jensen MK, Kaplan JL, Kellermayer R, Kociolek LK, Michail S, Oliva-Hemker M, Reed AW, Weatherly M, Kahn SA, Nicholson MR (2023). FECAL MICROBIOTA TRANSPLANTATION FOR CLOSTRIDIOIDES DIFFICILE INFECTION IN IMMUNOCOMPROMISED PEDIATRIC PATIENTS. J Pediatr Gastroenterol Nutr. (Read full article)
    7. Kastenberg ZJ, Deneau MR, OBrien EA, Huynh K, Book LS, Srivastava R, Jensen MK, Jaramillo CM, Guthery SL (2023). Fractionated Bilirubin Among 252 892 Utah Newborns with and Without Biliary Atresia: A 15-year Historical Birth Cohort Study. J Pediatr, 257, 113339. (Read full article)
    8. Bass LM, Ye W, Hawthorne K, Leung DH, Murray KF, Molleston JP, Romero R, Karpen S, Rosenthal P, Loomes KM, Wang KS, Squires RH, Miethke A, Ng VL, Horslen S, Kyle Jensen M, Sokol RJ, Magee JC, Shneider BL, ChiLDReN (2022). Risk of variceal hemorrhage and pretransplant mortality in children with biliary atresia. Hepatology, 76(3), 712-726. (Read full article)
    9. Lerret SM, Flynn E, White-Traut R, Alonso E, Mavis AM, Jensen MK, Peterson CG, Schiffman R (2022). Acceptability of an mHealth Family Self-management Intervention (myFAMI) for Pediatric Transplantation Families: Qualitative Focus. JMIR Nurs, 5(1), e39263. (Read full article)
    10. Shneider BL, Spino CA, Kamath BM, Magee JC, Ignacio RV, Huang S, Horslen SP, Molleston JP, Miethke AG, Kohli R, Leung DH, Jensen MK, Loomes KM, Karpen SJ, Mack C, Rosenthal P, Squires RH, Baker A, Rajwal S, Kelly D, Sokol RJ, Thompson RJ, for ChiLDReN and UK IMAGOIMAGINE Investigators (2022). Impact of long-term administration of maralixibat on children with cholestasis secondary to Alagille syndrome. Hepatol Commun, 6, 1922-1933. (Read full article)
    11. Nicholson MR, Alexander E, Ballal S, Davidovics Z, Docktor M, Dole M, Gisser JM, Goyal A, Hourigan SK, Jensen MK, Kaplan JL, Kellermayer R, Kelsen JR, Kennedy MA, Khanna S, Knackstedt ED, Lentine J, Lewis JD, Michail S, Mitchell PD, Oliva-Hemker M, Patton T, Queliza K, Sidhu S, Solomon AB, Suskind DL, Weatherly M, Werlin S, de Zoeten EF, Kahn SA, North American Society of Pediatric Gastroenterology and Nutrition Fecal Microbiota Transplantation Special Interest Group (2021). Efficacy and Outcomes of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease. J Crohns Colitis, 16, 768-777. (Read full article)
    12. Jaramillo C, Jensen MK, McClain A, Stoddard G, Barnhart D, Ermarth AK (2020). Clinical diagnostic predictive score for Meckel diverticulum. J Pediatr Surg, 56(9), 1673-1677. (Read full article)
    13. Lerret SM, Schiffman R, White-Traut R, Medoff-Cooper B, Ahamed SI, Adib R, Liegl M, Alonso E, Mavis A, Jensen K, Peterson CG, Neighbors K, Riordan MK, Semp MC, Vo T, Stendahl G, Chapman S, Unteutsch R, Simpson P (2021). Feasibility and Acceptability of a mHealth Self-Management Intervention for Pediatric Transplant Families. West J Nurs Res, 1939459211024656. (Read full article)
    14. Nicholson MR, Hourigan SK, Conrad M, Goyal A, Jensen K, Kelsen J, Kennedy M, Weatherly M, Kahn SA (2021). Current Challenges in Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children. Am J Gastroenterol. (Read full article)
    15. Deneau MR, Mack C, Perito ER, Ricciuto A, Valentino PL, Amin M, Amir AZ, Aumar M, Auth M, Broderick A, DiGuglielmo M, Draijer LG, Tavares Fagundes ED, El-Matary W, Ferrari F, Furuya KN, Gupta N, Hochberg JT, Homan M, Horslen S, Iorio R, Jensen MK, Jonas MM, Kamath BM, Kerkar N, Kim KM, Kolho KL, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Martinez M, Miethke A, Miloh T, Mogul D, Mohammad S, Mohan P, Moroz S, Ovchinsky N, Palle S, Papadopoulou A, Rao G, Rodrigues Ferreira A, Sathya P, Schwarz KB, Shah U, Shteyer E, Singh R, Smolka V, Soufi N, Tanaka A, Varier R, Vitola B, Woynarowski M, Zerofsky M, Zizzo A, Guthery SL (2020). The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children. Hepatology, 73(3), 1074-1087. (Read full article)
    16. Deneau MR, Mack C, Mogul D, Perito ER, Valentino PL, Amir AZ, DiGuglielmo M, Draijer LG, El-Matary W, Furuya KN, Gupta N, Hochberg JT, Horslen S, Jensen MK, Jonas MM, Kerkar N, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Martinez M, Miethke A, Miloh T, Mohammad S, Ovchinsky N, Rao G, Ricciuto A, Sathya P, Schwarz KB, Shah U, Singh R, Vitola B, Zizzo A, Guthery SL (2020). Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis. Hepatology, 73(3), 1061-1073. (Read full article)
    17. Shneider BL, Goodrich NP, Ye W, Sawyers C, Molleston JP, Merion RM, Leung DH, Karpen SJ, Kamath BM, Cavallo L, Wang K, Teckman JH, Squires JE, Sundaram SS, Rosenthal P, Romero R, Murray KF, Loomes KM, Jensen MK, Bezerra JA, Bass LM, Sokol RJ, Magee JC (2020). Nonfasted Liver Stiffness Correlates with Liver Disease Parameters and Portal Hypertension in Pediatric Cholestatic Liver Disease. Hepatol Commun, 4(11), 1694-1707. (Read full article)
    18. Venkat V, Ng VL, Magee JC, Ye W, Hawthorne K, Harpavat S, Molleston JP, Murray KF, Wang KS, Soufi N, Bass LM, Alonso EM, Bezerra JA, Jensen MK, Kamath BM, Loomes KM, Mack CL, Rosenthal P, Shneider BL, Squires RH, Sokol RJ, Karpen SJ, Childhood Liver Disease Research Network (2020). Modeling Outcomes in Children With Biliary Atresia With Native Liver After 2 Years of Age. Hepatol Commun, 4(12), 1824-1834. (Read full article)
    19. Shneider BL, Goodrich NP, Ye W, Sawyers C, Molleston JP, Merion RM, Leung DH, Karpen SJ, Kamath BM, Cavallo L, Wang K, Teckman JH, Squires JE, Sundaram SS, Rosenthal P, Romero R, Murray KF, Loomes KM, Jensen MK, Bezerra JA, Bass LM, Sokol RJ, Magee JC, Childhood Liver Disease Research Network ChiLDReN (2020). Nonfasted Liver Stiffness Correlates with Liver Disease Parameters and Portal Hypertension in Pediatric Cholestatic Liver Disease. Hepatol Commun, 4(11), 1694-1707. (Read full article)
    20. Nicholson MR, Mitchell PD, Alexander E, Ballal S, Bartlett M, Becker P, Davidovics Z, Docktor M, Dole M, Felix G, Gisser J, Hourigan SK, Jensen MK, Kaplan JL, Kelsen J, Kennedy M, Khanna S, Knackstedt E, Leier M, Lewis J, Lodarek A, Michail S, Oliva-Hemker M, Patton T, Queliza K, Russell GH, Singh N, Solomon A, Suskind DL, Werlin S, Kellermayer R, Kahn SA (2019). Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children. Clin Gastroenterol Hepatol, 18(3), 612-619.e1. (Read full article)
    21. Jaramillo C, Guthery SL, Lowichik A, Stoddard G, Kim T, Li Y, Jensen MK (2019). Quantitative Liver Fibrosis Using Collagen Hybridizing Peptide to Predict Native Liver Survival in Biliary Atresia: A Pilot Study. J Pediatr Gastroenterol Nutr, 70(1), 87-92. (Read full article)
    22. Deneau MR, Valentino PL, Mack C, Alqoaer K, Amin M, Amir AZ, Aumar M, Auth M, Broderick A, DiGuglielmo M, Draijer LG, El-Matary W, Ferrari F, Furuya KN, Gottrand F, Gupta N, Homan M, Jensen MK, Kamath BM, Kim KM, Kolho KL, Koot B, Iorio R, Martinez M, Miloh T, Mohan P, Palle S, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Varier R, Venkat V, Vitola B, Woynarowski M, Guthery S (2019). Assessing the Validity of Adult-derived Prognostic Models for Primary Sclerosing Cholangitis Outcomes in Children. J Pediatr Gastroenterol Nutr, 70(1), e12-e17. (Read full article)
    23. Deneau M, Perito E, Ricciuto A, Gupta N, Kamath BM, Palle S, Vitola B, Smolka V, Ferrari F, Amir AZ, Miloh T, Papadopoulou A, Mohan P, Mack C, Kolho KL, Iorio R, El-Matary W, Venkat V, Chan A, Saubermann L, Valentino PL, Shah U, Miethke A, Lin H, Jensen MK (2019). Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course. J Pediatr, 209, 92-96.e1. (Read full article)
    24. Laborda TJ, Jensen MK, Kavan M, Deneau M (2019). Treatment of primary sclerosing cholangitis in children. World J Hepatol, 11(1), 19-36. (Read full article)
    25. Davidovics, Zev H, Michail, Sonia, Nicholson, Maribeth R, Kociolek, Larry K, Pai, Nikhil, Hansen, Richard, Schwerd, Tobias, Maspons, Aldo, Shamir, Raanan, Szajewska, Hania, Thapar, Nikhil, de Meij, Tim, Mosca, Alexis, Vandenplas, Yvan, Kahn, Stacy A, Kellermayer, Richard, and the FMT Special Interest Group of the North American Society of Pediatric Gastroenterology Hepatology, Nutrition, the European Society for Pediatric Gastroenterology (12/11/2018). Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr.
    26. Barfuss S, Knackstedt ED, Jensen K, Molina K, Lal A (2018). Cardiac allograft vasculopathy following fecal microbiota transplantation for recurrent C. difficile infection. Transpl Infect Dis, 20(6), e12983. (Read full article)
    27. Deneau MR, Mack C, Abdou R, Amin M, Amir A, Auth M, Bazerbachi F, Marie Broderick A, Chan A, DiGuglielmo M, El-Matary W, El-Youssef M, Ferrari F, Furuya KN, Gottrand F, Gupta N, Homan M, Jensen MK, Kamath BM, Mo Kim K, Kolho KL, Konidari A, Koot B, Iorio R, Martinez M, Mohan P, Palle S, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Valentino PL, Varier R, Venkat V, Vitola B, Vos MB, Woynarowski M, Yap J, Miloh T (2018). Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis. Hepatol Commun, 2(11), 1369-1378. (Read full article)
    28. Deneau MR, Mack C, Abdou R, Amin M, Amir A, Auth M, Bazerbachi F, Marie Broderick A, Chan A, DiGuglielmo M, El-Matary W, El-Youssef M, Ferrari F, Furuya KN, Gottrand F, Gupta N, Homan M, Jensen MK, Kamath BM, Mo Kim K, Kolho KL, Konidari A, Koot B, Iorio R, Martinez M, Mohan P, Palle S, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Valentino PL, Varier R, Venkat V, Vitola B, Vos MB, Woynarowski M, Yap J, Miloh T (2018). Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis. Hepatol Commun, 2(11), 1369-1378. (Read full article)
    29. Deneau MR, El-Matary W, Valentino PL, Abdou R, Alqoaer K, Amin M, Amir AZ, Auth M, Bazerbachi F, Broderick A, Chan A, Cotter J, Doan S, El-Youssef M, Ferrari F, Furuya KN, Gottrand M, Gottrand F, Gupta N, Homan M, Kamath BM, Kim KM, Kolho KL, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Varier R, Venkat V, Vitola B, Vos MB, Woynarowski M, Yap J, Jensen MK (2017). The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration. Hepatology, 66(2), 518-527. (Read full article)
    30. Varier RU, Biltaji E, Smith KJ, Roberts MS, Jensen MK, LaFleur J, Nelson RE (2015). Cost-Effectiveness Analysis of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. Infect Control Hosp Epidemiol, 36(4), 438-444. (Read full article)
    31. Elizabeth Parsons C, Nelson R, Book LS, Kyle Jensen M (2014). Renal replacement therapy in infants and children with hepatorenal syndrome awaiting liver transplantation: a case-control study. Liver Transpl, 20(12), 1468-74. (Read full article)
    32. Deneau M, Book LS, Guthery SL, Jensen MK (2014). Outcome after discontinuation of immunosuppression in children with autoimmune hepatitis: a population-based study. J Pediatr, 164(4), 714-719.e2. (Read full article)
    33. Deneau M, Jensen MK, Holmen J, Williams MS, Book LS, Guthery SL (2013). Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Hepatology, 58(4), 1392-400. (Read full article)
    34. Jensen MK, Campbell KM, Alonso MH, Nathan JD, Ryckman FC, Tiao GM (2013). Management and long-term consequences of portal vein thrombosis after liver transplantation in children. Liver Transpl, 19(3), 315-21. (Read full article)
    35. Jensen MK, Biank VF, Moe DC, Simpson PM, Li SH, Telega GW (2012). HIDA, percutaneous transhepatic cholecysto-cholangiography and liver biopsy in infants with persistent jaundice: can a combination of PTCC and liver biopsy reduce unnecessary laparotomy? Pediatr Radiol, 42(1), 32-9. (Read full article)
    36. Jensen MK, Tipnis NA, Bajorunaite R, Sheth MK, Sato TT, Noel RJ (2010). Capsule endoscopy performed across the pediatric age range: indications, incomplete studies, and utility in management of inflammatory bowel disease. Gastrointest Endosc, 72(1), 95-102. (Read full article)

    Review

    1. Laborda TJ, Jensen MK, Kavan M, Deneau M (2019). Treatment of primary sclerosing cholangitis in children. [Review]. World J Hepatol, 11(1), 19-36. (Read full article)

    Book Chapter

    1. Jensen MK, Balistreri WF (2015). Viral Hepatitis. In Robert Kliegman, Bonita Stanton, Richard Behrman, Joseph St. Geme and Nina Schor (Eds.), Nelson Textbook of Pediatrics (20, pp. 1942-53). Philadelpha: Elsevier.
    2. Sampert C, Jensen MK (2014). Esophageal Varices. In Pohl / Jolley / Gelfond (Ed.), Pediatric Gastroenterology – A Color Handbook (1st). London: Manson Publishing.
    3. Jensen MK, Alonso MA, Nathan JD, Ryckman FC, Tiao G, Balistreri WF (2014). Liver Transplantation in Children: Indications and Surgical Aspects. In Suchy, Sokol, Balistreri WF (Eds.), Liver disease in Children (4th, pp. 760-772). Cambridge, UK: Cambridge University Press.
    4. Jensen MK, Telega G (2008). Infections of the Liver and Biliary Tract. In Rudolph, Lister, Gershon, First, Rudolph (Eds.), Rudolph’s Pediatrics (22nd). New York, New York: McGraw-Hill.

    Letter

    1. Ermarth A, Jensen MK (2020). A North American Serologic-based Celiac Disease Diagnosis: If Not Now, Then When? [Letter to the editor]. J Pediatr Gastroenterol Nutr, 70(5), e107. (Read full article)

    Abstract

    1. Pachal P, Kahn S, Zellmer C, Kassam Z, Osman M, Allegretti J, Seng M, Budree, AB, NASPGHAN FMT Special Interest Group (11/26/2018). Scaling Pediatric Access to Fecal Microbiota Transplantation in the United States: A Time-Series Geospatial Analysis. [Abstract]. Open Forum Infectious Disease, 5(suppl_1), 197.
  • News & Podcasts